Lantheus Medical Imaging Inc - Product Pipeline Analysis, 2018 Update

Lantheus Medical Imaging Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME25538PD
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imaging. The company's major products include ultrasound contrast agents, inhalable and injectable radiopharmaceutical imaging agents, and technetium-based generators. Its products are used to diagnose coronary artery disease, stroke, congestive heart failure, cancerous tumors and other diseases. Lantheus Medical develops its products using positron emission tomography and magnetic resonance imaging technologies. The company offers its products to nuclear physicians, internal medicine physicians, cardiologists, radiologists, technologists and sonographers. Lantheus Medical is headquartered in North Billerica, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Lantheus Medical Imaging Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Lantheus Medical Imaging Inc Company Overview 5

Lantheus Medical Imaging Inc Company Snapshot 5

Lantheus Medical Imaging Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Lantheus Medical Imaging Inc-Pipeline Analysis Overview 7

Business Description 7

Lantheus Medical Imaging Inc-Key Facts 7

Lantheus Medical Imaging Inc-Major Products and Services 8

Lantheus Medical Imaging Inc Pipeline Products by Development Stage 9

Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11

Lantheus Medical Imaging Inc Pipeline Products Overview 14

DEFINITY 14

DEFINITY Product Overview 14

DEFINITY Clinical Trial 15

Flurpiridaz F 18 26

Flurpiridaz F 18 Product Overview 26

LMI 1174 27

LMI 1174 Product Overview 27

LMI 1195 28

LMI 1195 Product Overview 28

Next-Generation DEFINITY 29

Next-Generation DEFINITY Product Overview 29

Lantheus Medical Imaging Inc-Key Competitors 30

Lantheus Medical Imaging Inc-Key Employees 31

Lantheus Medical Imaging Inc-Key Employee Biographies 32

Lantheus Medical Imaging Inc-Locations And Subsidiaries 33

Head Office 33

Recent Developments 34

Lantheus Medical Imaging Inc, Recent Developments 34

May 02, 2018: Lantheus Holdings Announces 2018 First Quarter Financial Results 34

Mar 12, 2018: Lantheus Presents New Data on Novel Cardiac PET Imaging Agent LMI 1195 in Development for the Diagnostic Assessment of Ischemic Heart Failure Patients at Risk for Sudden Cardiac Death at ACC.18 34

Feb 27, 2018: Lantheus Holdings Names Gary Pruden, Kenneth Pucel and Dr. James Thrall to its Board of Directors 35

Nov 02, 2017: Lantheus Holdings Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance 36

May 02, 2017: Lantheus Holdings Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance 36

Mar 30, 2017: Lantheus Announces Refinancing of its Debt Facility 37

Feb 21, 2017: Lantheus Holdings Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance 38

Feb 02, 2017: Lantheus Medical Imaging Announces FDA Approval of DEFINITY Label Update 38

Jan 26, 2017: Lantheus Holdings Appoints New Member to its Board of Directors 39

Nov 01, 2016: Lantheus Holdings Reports 2016 Third Quarter Financial Results 39

Appendix 41

Methodology 41

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Lantheus Medical Imaging Inc Pipeline Products by Equipment Type 6

Lantheus Medical Imaging Inc Pipeline Products by Development Stage 9

Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11

List of Tables

Lantheus Medical Imaging Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Lantheus Medical Imaging Inc Pipeline Products by Equipment Type 6

Lantheus Medical Imaging Inc Pipeline Products by Indication 6

Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 6

Lantheus Medical Imaging Inc, Key Facts 7

Lantheus Medical Imaging Inc, Major Products and Services 8

Lantheus Medical Imaging Inc Number of Pipeline Products by Development Stage 9

Lantheus Medical Imaging Inc Pipeline Products Summary by Development Stage 10

Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11

Lantheus Medical Imaging Inc Ongoing Clinical Trials Summary 12

DEFINITY-Product Status 14

DEFINITY-Product Description 14

DEFINITY-2D and 4D Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Chemoembolization 15

DEFINITY-Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture 15

DEFINITY-Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound 15

DEFINITY-Augmentation of Limb Perfusion with Contrast Ultrasound 16

DEFINITY-Comparison of the Sensitivity and Specificity of Acoustic Angiography (Micro-tumor Detection by Quantifying Tumor-induced Vascular Abnormalities) to the Sensitivity and Specificity of Conventional Ultrasound 16

DEFINITY-Contrast Enhanced Intracardiac Echocardiography (ICE) for Localization of Myocardial Scar During Ablation of Ventricular Tachycardia 16

DEFINITY-Contrast Enhanced Voiding Urosonography (ceVUS) with the Intravesical Administration of the Ultrasound Contrast Agent OPTISON for Vesicoureteral Reflux Detection and Urethral Imaging in Children 17

DEFINITY-Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients with CKD (CEUS CKD) 17

DEFINITY-Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients with CKD Extension: CEUS CKDx 17

DEFINITY-Contrast-enhanced Ultrasound for Follow-up after Radiofrequency Ablation of Renal Lesions: A Prospective, Blinded Study 18

DEFINITY-Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging: A Pilot Study 18

DEFINITY-Perflutren Protein-Type A Microspheres and Contrast-enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients with Liver Cancer 19

DEFINITY-Peripheral Blood Flow Responses to Electromagnetic Energy 20

DEFINITY-Pilot-Study-Incorporating Contrast-enhanced Ultrasound (CEUS) to Real-time MRI / Ultrasound Fusion Imaging for Prostate Biopsies 20

DEFINITY-Prospective Analysis and Comparison of Conventional Stress Echocardiograms and Real-Time Myocardial Contrast Stress Echocardiogram; for Bristol-Myers Squibb Medical Imaging: The Definity RT-P During DSE Database 20

DEFINITY-Quantitative Subharmonic Breast Imaging 21

DEFINITY-Quantitative Subharmonic Breast Imaging: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy 21

DEFINITY-Real Time Contrast Enhanced Ultrasound and Ultrasound-based Elastography: Novel Techniques in Assessment of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer 21

DEFINITY-Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Cardiac Transplant Patients: RTMPE for CAV 22

DEFINITY-Real-time Contrast Enhanced Ultrasound and Ultrasound-based Elastography: Novel Quantitative Imaging Techniques for Early Therapy Response Assessment in Sarcomas 22

DEFINITY-Safety and Feasibility of Primary Motor Cortex Blood-brain Barrier Opening Using Transcranial MR-Guided Focused Ultrasound with Intravenous Ultrasound Contrast Agent in Patients with Amyotrophic Lateral Sclerosis 23

DEFINITY-Sonothrombolysis in Patients with an ST-segment Elevation Myocardial Infarction. A Prospective Single-arm Study 23

DEFINITY-The Impact of Real-time Myocardial Perfusion Echocardiography on Diagnostic Confidence and Subsequent Management of Myocardial Ischemia in the Intensive Care Unit: RTMPE in the ICU 23

DEFINITY-The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity 24

DEFINITY-The Use of Optison Echocardiography Contrast in the Detection of Left Atrial Appendage Thrombus with Transesophageal Echocardiography 24

DEFINITY-Therapeutic Use of Ultrasound in Acute Coronary Artery Disease 24

DEFINITY-Use of Definity Contrast Agent for Ultrasound of Intraocular Tumors 25

DEFINITY-Use of Reactivated DEFINITY in Patients Undergoing Stress Echo 25

DEFINITY-Vasodilatory Effects of Light on Peripheral Artery Disease 25

Flurpiridaz F 18-Product Status 26

Flurpiridaz F 18-Product Description 26

LMI 1174-Product Status 27

LMI 1174-Product Description 27

LMI 1195-Product Status 28

LMI 1195-Product Description 28

Next-Generation DEFINITY-Product Status 29

Next-Generation DEFINITY-Product Description 29

Lantheus Medical Imaging Inc, Key Employees 31

Lantheus Medical Imaging Inc, Key Employee Biographies 32

Glossary 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Voyager Imaging

GE Healthcare LLC

Philips Healthcare

Mallinckrodt LLC

Bayer HealthCare Pharmaceuticals

Ion Beam Applications SA

Bracco Diagnostics Inc

Lantheus Medical Imaging Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53235
Site License
USD 1500 INR 106470
Corporate User License
USD 2250 INR 159705

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com